ANI Pharma (NASDAQ: ANIP) reported Q1 EPS of $0.57, $0.01 better than the analyst estimate of $0.56. Revenue for the quarter came in at $18.8 million versus the consensus estimate of $19.9 million.

For earnings history and earnings-related data on ANI Pharma (ANIP) click here.